(Q36382260)

13 August 2017

1 reference

title

Reversal of hepatic fibrosis -- fact or fantasy? (English)

1 reference

13 August 2017

Scott L Friedman

1

1 reference

PubMed ID

16447275

13 August 2017

Meena B Bansal

series ordinal

2

1 reference

PubMed ID

16447275

13 August 2017

language of work or name

English

0 references

publication date

1 February 2006

1 reference

13 August 2017

1 reference

13 August 2017

43

1 reference

13 August 2017

2 Suppl 1

1 reference

13 August 2017

S82-8

1 reference

Sampling variability of liver fibrosis in chronic hepatitis C.

13 August 2017

1 reference

Reversibility of cirrhosis in patients cured of thalassemia by bone marrow transplantation

21 January 2018

1 reference

Nuclear factor-kappaB1 (p50) limits the inflammatory and fibrogenic responses to chronic injury

21 January 2018

1 reference

Hepatocytes express nerve growth factor during liver injury: evidence for paracrine regulation of hepatic stellate cell apoptosis

21 January 2018

1 reference

Lysyl oxidase: mechanism, regulation and relationship to liver fibrosis

21 January 2018

1 reference

Hepatic fibrosis. Correlation of biochemical and morphologic investigations

21 January 2018

1 reference

7 January 2021

Collagenase activity in experimental hepatic fibrosis

1 reference

7 January 2021

Proline trapping in granulomas, the site of collagen biosynthesis in murine schistosomiasis

1 reference

7 January 2021

Granuloma collagenase and EDTA-sensitive neutral protease production in hepatic murine schistosomiasis

1 reference

7 January 2021

Collagen production by rat hepatocytes and sinusoidal cells in primary monolayer culture

1 reference

7 January 2021

Nonparenchymal cells cultivated from explants of fibrotic liver resemble endothelial and smooth muscle cells from blood vessel walls

1 reference

7 January 2021

Purified Rat Liver Fat-Storing Cells in Culture Divide and Contain Collagen

1 reference

7 January 2021

Cirrhosis reversal: a duel between dogma and myth

1 reference

7 January 2021

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

7 January 2021

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

1 reference

7 January 2021

Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection

1 reference

7 January 2021

Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease

1 reference

7 January 2021

Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal

1 reference

7 January 2021

Host genetic factors influence disease progression in chronic hepatitis C.

1 reference

7 January 2021

Natural history of hepatitis C

1 reference

7 January 2021

Prevalence of Hepatitis C–Related Cirrhosis in Elderly Asian Patients Infected in Childhood

1 reference

7 January 2021

Is cirrhosis an inevitable consequence of chronic hepatitis C virus infection?

1 reference

7 January 2021

Nonalcoholic fatty liver disease

1 reference

7 January 2021

Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients

1 reference

7 January 2021

Reversibility of hepatic fibrosis in autoimmune hepatitis

1 reference

7 January 2021

Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct

1 reference

7 January 2021

Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss

1 reference

7 January 2021

Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis

1 reference

7 January 2021

Decreasing fibrogenesis: an immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis B.

1 reference

7 January 2021

Histological outcome during long-term lamivudine therapy.

1 reference

7 January 2021

Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy

1 reference

7 January 2021

Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C.

1 reference

7 January 2021

Long-term benefit of interferon alpha therapy of chronic hepatitis D: regression of advanced hepatic fibrosis.

1 reference

7 January 2021

Is liver fibrosis reversible?

1 reference

7 January 2021

Targeted treatments for cirrhosis

1 reference

7 January 2021

Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B

1 reference

7 January 2021

Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications

1 reference

7 January 2021

1 reference

7 January 2021

Roles of TGF-beta in hepatic fibrosis

1 reference

7 January 2021

Cirrhosis: new research provides a basis for rational and targeted treatments

1 reference

7 January 2021

PDGF and signal transduction in hepatic stellate cells

1 reference

7 January 2021

A dual reporter gene transgenic mouse demonstrates heterogeneity in hepatic fibrogenic cell populations.

1 reference

7 January 2021

Expression of Smads during in vitro transdifferentiation of hepatic stellate cells to myofibroblasts

1 reference

7 January 2021

Smads 2 and 3 are differentially activated by transforming growth factor-beta (TGF-beta ) in quiescent and activated hepatic stellate cells. Constitutive nuclear localization of Smads in activated cells is TGF-beta-independent.

1 reference

7 January 2021

Treatment with human metalloproteinase-8 gene delivery ameliorates experimental rat liver cirrhosis.

1 reference

7 January 2021

A cut above the rest? MMP-8 and liver fibrosis gene therapy

1 reference

7 January 2021

Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair

1 reference

7 January 2021

Extracellular matrix degradation and the role of hepatic stellate cells

1 reference

7 January 2021

Essential Role of Matrix Metalloproteinases in Interleukin-1-induced Myofibroblastic Activation of Hepatic Stellate Cell in Collagen

1 reference

7 January 2021

Mutation in collagen-1 that confers resistance to the action of collagenase results in failure of recovery from CCl4-induced liver fibrosis, persistence of activated hepatic stellate cells, and diminished hepatocyte regeneration

1 reference

7 January 2021

Expression of matrix metalloproteinase-2 and -14 persists during early resolution of experimental liver fibrosis and might contribute to fibrolysis

1 reference

7 January 2021

Hepatic stellate cell behavior during resolution of liver injury

1 reference

7 January 2021

Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors

1 reference

7 January 2021

Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis

1 reference

7 January 2021

Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model

1 reference

7 January 2021

Inhibition of inhibitor of kappaB kinases stimulates hepatic stellate cell apoptosis and accelerated recovery from rat liver fibrosis.

1 reference

7 January 2021

Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking

1 reference

7 January 2021

Expression of cytosolic and membrane associated tissue transglutaminase in rat hepatic stellate cells and its upregulation during transdifferentiation to myofibroblasts in culture.

1 reference

7 January 2021

Biochemical and immunochemical study of lysyl oxidase in experimental hepatic fibrosis in the rat

1 reference

7 January 2021

Conversion of micronodular cirrhosis into macronodular cirrhosis

1 reference

7 January 2021

Delivery of matrix metalloproteinase-1 attenuates established liver fibrosis in the rat.

1 reference

7 January 2021

Hepatic stellate cells as a target for the treatment of liver fibrosis

1 reference

7 January 2021

Hepatic fibrosis: from bench to bedside

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.20974

1 reference

13 August 2017

1 reference

PubMed ID

16447275